Published in Protein Sci on November 01, 1996
Contribution of residue B5 to the folding and function of insulin and IGF-I: constraints and fine-tuning in the evolution of a protein family. J Biol Chem (2009) 0.85
Insulin: a small protein with a long journey. Protein Cell (2010) 0.81
Synthesis and NMR solution structure of an alpha-helical hairpin stapled with two disulfide bridges. Protein Sci (2000) 0.81
Theoretical and computational studies of peptides and receptors of the insulin family. Membranes (Basel) (2015) 0.77
The effect of cell disruption techniques and chaotropic agents on the downstream purification process of mecasermin produced as inclusion body in E. coli. Res Pharm Sci (2016) 0.75
Probing Receptor Specificity by Sampling the Conformational Space of the Insulin-like Growth Factor II C-domain. J Biol Chem (2016) 0.75
Direct determination of the binding sites of cisplatin on insulin-like growth factor-1 by top-down mass spectrometry. J Biol Inorg Chem (2014) 0.75
Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins (1991) 36.69
The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry (1992) 9.40
Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J (1986) 6.62
Receptor binding redefined by a structural switch in a mutant human insulin. Nature (1991) 1.68
The biological activity and the binding affinity of modified insulins determined on isolated rat fat cells. Diabetologia (1974) 1.42
Insulin-like growth factor: a model for tertiary structure accounting for immunoreactivity and receptor binding. Proc Natl Acad Sci U S A (1978) 1.32
The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site. Proc Natl Acad Sci U S A (1991) 1.14
Structure and evolution of insulins: implications for receptor binding. Bioessays (1992) 1.14
Protein structures from NMR. Biochemistry (1988) 1.11
Single chain des-(B30) insulin. Intramolecular crosslinking of insulin by trypsin catalyzed transpeptidation. Int J Pept Protein Res (1985) 1.09
The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor. J Biol Chem (1990) 1.02
Importance of aliphatic side-chain structure at positions 2 and 3 of the insulin A chain in insulin-receptor interactions. Biochemistry (1992) 1.01
Mutants of human insulin-like growth factor I with reduced affinity for the type 1 insulin-like growth factor receptor. Biochemistry (1988) 0.98
Perturbation of insulin-receptor interactions by intramolecular hormone cross-linking. Analysis of relative movement among residues A1, B1, and B29. J Biol Chem (1989) 0.97
Dynamics of a monomeric insulin analogue: testing the molten-globule hypothesis. Biochemistry (1993) 0.95
Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3. J Biol Chem (1996) 0.92
An insulin with the native sequence but virtually no activity. Biol Chem Hoppe Seyler (1994) 0.88
NalphaA1-N-epsilon B-29-crosslinked diaminosuberoylinsulin, a potential intermediate for the chemical synthesis of insulin. Hoppe Seylers Z Physiol Chem (1975) 0.85
The generation of a ColE1-Apr cloning vehicle which allows detection of inserted DNA. Mol Gen Genet (1975) 8.80
Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol (1998) 5.64
Analysis of sequences transposed by complementation of two classes of transposition-deficient mutants of Tn3. J Bacteriol (1978) 3.69
General practice research in the Journal. Br J Gen Pract (1991) 3.51
Use of partial cardiopulmonary bypass during the anhepatic phase of orthotopic liver grafting. Lancet (1979) 2.98
False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol (1997) 2.84
I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat Biotechnol (1997) 2.47
Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res (1991) 2.30
Polypeptides expressed in Escherichia coli K-12 minicells by transposition elements Tn1 and Tn3. J Bacteriol (1979) 2.17
Receptor-binding region of insulin. Nature (1976) 2.14
Computer simulation model of an x-ray department. Br Med J (1972) 1.80
Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A. Biochem J (2001) 1.61
Chromosome rearrangements for the control of insect pests. Science (1972) 1.61
What influences doctors' prescribing? Sore throats revisited. J R Coll Gen Pract (1989) 1.61
Hours of work and fatigue in doctors. J R Coll Gen Pract (1988) 1.59
Epidermal growth factor binding induces a conformational change in the external domain of its receptor. EMBO J (1989) 1.56
Application of lipovitellin-salt-mannitol agar for screening, isolation, and presumptive identification of Staphylococcus aureus in a teaching hospital. J Clin Microbiol (1996) 1.55
Determination of interspin distances between spin labels attached to insulin: comparison of electron paramagnetic resonance data with the X-ray structure. Biophys J (1997) 1.48
Trainee representation in anaesthesia--past, present and future. Anaesthesia (1996) 1.39
Three different putative phosphate transport receptors are encoded by the Mycobacterium tuberculosis genome and are present at the surface of Mycobacterium bovis BCG. J Bacteriol (1997) 1.38
Conformational flexibility in a small globular hormone: x-ray analysis of avian pancreatic polypeptide at 0.98-A resolution. Biopolymers (1983) 1.33
Lloyd-Davies position with Trendelenburg--a disaster waiting to happen? Dis Colon Rectum (1999) 1.33
Shared decision-making in the informed treatment of acute otitis media. Practitioner (1987) 1.31
Counselling patients to make lifestyle changes: the role of physician self-efficacy, training and beliefs about causes. Fam Pract (1993) 1.23
The relation of conformation and association of insulin to receptor binding; x-ray and circular-dichroism studies on bovine and hystricomorph insulins. Eur J Biochem (1975) 1.21
Female twin with Hunter disease due to nonrandom inactivation of the X-chromosome: a consequence of twinning. Am J Med Genet (1992) 1.18
Autonomy in medical ethics after O'Neill. J Med Ethics (2005) 1.15
Metabolism of metaxalone. J Med Chem (1966) 1.13
Covalent structure of two novel neutrophile leucocyte-derived proteins of porcine and human origin. Neutrophile elastase homologues with strong monocyte and fibroblast chemotactic activities. Eur J Biochem (1991) 1.13
Conformational studies on the pancreatic polypeptide hormone family. Eur J Biochem (1984) 1.11
Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction. J Biol Chem (2001) 1.10
Identification of two novel regions of human IL-6 responsible for receptor binding and signal transduction. J Immunol (1994) 1.09
Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex. J Biol Chem (1997) 1.08
Patient satisfaction: the indispensable outcome. Manag Care (1999) 1.07
Autogenous hard palate mucosa: the ideal lower eyelid spacer? Br J Ophthalmol (2001) 1.07
Parallel gene expression monitoring using oligonucleotide probe arrays of multiple transcripts with an animal model of focal ischemia. J Cereb Blood Flow Metab (2000) 1.06
Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes. J Immunol (1999) 1.06
Failure to recognize psychogenic nonepileptic seizures may cause death. Neurology (2004) 1.06
Morphological identification of alpha-1-antitrypsin in pulmonary macrophages. Hum Pathol (1979) 1.05
High resolution structure of BipD: an invasion protein associated with the type III secretion system of Burkholderia pseudomallei. J Mol Biol (2006) 1.04
The family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexes. Proteins (1997) 1.04
Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins. Biochem J (2001) 1.02
Reflex sympathetic dystrophy associated with malignancy. Arthritis Rheum (1985) 1.01
Diagnostic labels, treatment and outcome in acute sore throat. Practitioner (1988) 1.01
Cooperativity and intermediate states in the T----R-structural transformation of insulin. Biol Chem Hoppe Seyler (1990) 1.01
Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation. J Neurosci (1988) 1.01
Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition. Neuropharmacology (2003) 1.00
Associations between primary care physician satisfaction and self-reported aspects of utilization management. Health Serv Res (2000) 0.99
Novel expression and function of peroxisome proliferator-activated receptor gamma (PPARgamma) in human neuroblastoma cells. Clin Cancer Res (2001) 0.99
A bioinformatical approach suggests the function of the autoimmune hepatitis target antigen soluble liver antigen/liver pancreas. Hepatology (2001) 0.99
Morphoregulatory role of thidiazuron : substitution of auxin and cytokinin requirement for the induction of somatic embryogenesis in geranium hypocotyl cultures. Plant Physiol (1992) 0.99
A monomeric insulin from the porcupine (Hystrix cristata), an Old World hystricomorph. Nature (1980) 0.98
Human herpes virus 8 interleukin-6 homologue triggers gp130 on neuronal and hematopoietic cells. Eur J Biochem (2000) 0.98
Characterization and binding specificity of the monomeric STAT3-SH2 domain. J Biol Chem (1999) 0.98
Receptor recognition sites of cytokines are organized as exchangeable modules. Transfer of the leukemia inhibitory factor receptor-binding site from ciliary neurotrophic factor to interleukin-6. J Biol Chem (1999) 0.97
Mechanism of thiamine uptake by human jejunal brush-border membrane vesicles. Am J Physiol Cell Physiol (2001) 0.97
Induction by thidiazuron of somatic embryogenesis in intact seedlings of peanut. Planta (1992) 0.97
Site-directed mutagenesis and X-ray crystallography of the PQQ-containing quinoprotein methanol dehydrogenase and its electron acceptor, cytochrome c(L). Biochemistry (2001) 0.97
Comparison of dacryocystography and lacrimal scintigraphy in the diagnosis of functional nasolacrimal duct obstruction. Br J Ophthalmol (1999) 0.97
Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin. Endocrinology (1999) 0.96
Interleukin-6 and related cytokines: effect on the acute phase reaction. Z Ernahrungswiss (1998) 0.96
Calculations of the CD spectrum of bovine pancreatic ribonuclease. Biopolymers (1997) 0.96
The atomic resolution structure of methanol dehydrogenase from Methylobacterium extorquens. Acta Crystallogr D Biol Crystallogr (2004) 0.96
Selective extraction of small and large molecules from the cerebrospinal fluid by Purkinje neurons. Science (1985) 0.96
The interaction between MK-801 and receptors for N-methyl-D-aspartate: functional consequences. Neuropharmacology (1987) 0.95
Receptor-binding assay of chemically modified insulins. Comparison with in vitro and in vivo bioassays. Diabetologia (1974) 0.95
Determination of the three-dimensional solution structure of the histidine-containing phosphocarrier protein HPr from Escherichia coli using multidimensional NMR spectroscopy. Eur J Biochem (1992) 0.94
Systemic inhibition of spontaneous calcification by the serum protein alpha 2-HS glycoprotein/fetuin. Z Kardiol (2001) 0.94
Protein engineering of chymosin; modification of the optimum pH of enzyme catalysis. Protein Eng (1990) 0.94
Patterns of junctional communication in animal tissues. Ciba Found Symp (1987) 0.93
Analysis of barbiturates in blood by high-performance liquid chromatography. J Chromatogr (1981) 0.93
The effect of a non-peptide interchain crosslink on the reoxidation of reduced insulin. Hoppe Seylers Z Physiol Chem (1973) 0.93
Benzoylformate decarboxylase from Pseudomonas putida as stable catalyst for the synthesis of chiral 2-hydroxy ketones. Chemistry (2000) 0.92
Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor. FEBS Lett (2000) 0.92
[The structure of proteoglycans from the cornea]. Hoppe Seylers Z Physiol Chem (1971) 0.92
MMP-9-hemopexin domain hampers adhesion and migration of colorectal cancer cells. Int J Oncol (2007) 0.92
Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3. J Biol Chem (1996) 0.92
Adaptation of plasminogen activator sequences to known protease structures. FEBS Lett (1983) 0.92
Structural organization of the human insulin receptor ectodomain. J Biol Chem (1992) 0.92
Distinction of structural reorganisation and ligand binding in the T<==>R transition of insulin on the basis of allosteric models. Biol Chem Hoppe Seyler (1993) 0.92
[Preparation and properties of acetyl derivatives of beef insulin. I]. Hoppe Seylers Z Physiol Chem (1972) 0.91
Active site mutants of pyruvate decarboxylase from Zymomonas mobilis--a site-directed mutagenesis study of L112, I472, I476, E473, and N482. Eur J Biochem (1998) 0.91
The T<-->R structural transition of insulin; pathways suggested by targeted energy minimization. Protein Eng (1992) 0.91
Reduction/reoxidation studies with cross-linked insulin derivatives. Hoppe Seylers Z Physiol Chem (1974) 0.91
A shortened insulin with full in vitro potency. Biol Chem Hoppe Seyler (1985) 0.90
Is caspase-3 inhibition a valid therapeutic strategy in cerebral ischemia? Drug Discov Today (2001) 0.90
Regulation of butyrate uptake in Caco-2 cells by phorbol 12-myristate 13-acetate. Am J Physiol Gastrointest Liver Physiol (2003) 0.90
Analysis of the human interleukin-6/human interleukin-6 receptor binding interface at the amino acid level: proposed mechanism of interaction. Blood (1997) 0.90
The membrane proximal cytokine receptor domain of the human interleukin-6 receptor is sufficient for ligand binding but not for gp130 association. J Biol Chem (1998) 0.89